Microevolution during serial mouse passage demonstrates FRE3 as a virulence adaptation gene in Cryptococcus neoformans

mBio

Volumn 5, Issue 2, 2014, Pages

  Hu, Guowu ^a   Chen, Shu Hui ^a   Qiu, Jin ^a   Bennett, John E ^a   Myers, Timothy G ^a   Williamson, Peter R ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER REDUCTASE; IRON REDUCTASE; MELANIN; OXIDOREDUCTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; FRE3 GENE; FUNGAL GENE; FUNGAL STRAIN; FUNGAL VIRULENCE; FUNGUS GROWTH; GENE EXPRESSION; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; TRANSCRIPTOMICS;

ADAPTATION, BIOLOGICAL; ANIMALS; CELL LINE; CRYPTOCOCCUS NEOFORMANS; ENVIRONMENTAL MICROBIOLOGY; FMN REDUCTASE; MACROPHAGES; MICE; SEQUENCE ANALYSIS, DNA; SERIAL PASSAGE; TRANSCRIPTOME; VIRULENCE; VIRULENCE FACTORS;

EID: 84899741885     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00941-14     Document Type: Article

References (67)

1. Ebert D. 1998. Experimental evolution of parasites. Science 282: 1432-1435. http://dx.doi.org/10.1126/science.282.5393.1432.
2. Steenbergen JN, Shuman HA, Casadevall A. 2001. Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages. Proc. Natl. Acad. Sci. U. S. A. 98:15245-15250. http://dx.doi.org/10.1073/pnas.261418798.
3. Warpeha KM, Park YD, Williamson PR. 2013. Susceptibility of intact germinating Arabidopsis thaliana to the human fungal pathogen Cryptococcus. Appl. Environ. Microbiol. 79:2979-2988. http://dx.doi.org/ 10.1128/AEM.03697-12.
4. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. 2009. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23:525-530. http://dx.doi.org/10.1097/QAD.0b013e328322ffac.
5. Pyrgos V, Seitz AE, Steiner CA, Prevots DR, Williamson PR. 2013. Epidemiology of cryptococcal meningitis in the US: 1997-2009. PLoS One 8:e56269. http://dx.doi.org/10.1371/journal.pone.0056269.
6. Chen LC, Goldman DL, Doering TL, Pirofski La, Casadevall A. 1999. Antibody response to Cryptococcus neoformans proteins in rodents and humans. Infect. Immun. 67:2218-2224.
7. Goldman DL, Khine H, Abadi J, Lindenberg DJ, Pirofski La, Niang R, Casadevall A. 2001. Serologic evidence for Cryptococcus neoformans infection in early childhood. Pediatrics 107:E66. http://dx.doi.org/10.1542/ peds.107.5.e66.
8. Garcia-Hermoso D, Janbon G, Dromer F. 1999. Epidemiological evidence for dormant Cryptococcus neoformans infection. J. Clin. Microbiol. 37:3204-3209.
9. McClelland EE, Adler FR, Granger DL, Potts WK. 2004. Major histocompatibility complex controls the trajectory but not host-specific adaptation during virulence evolution of the pathogenic fungus Cryptococcus neoformans. Proc. Biol. Sci. 271:1557-1564. http://dx.doi.org/10.1098/ rspb.2004.2736.
10. McClelland EE, Granger DL, Potts WK. 2003. Major histocompatibility complex-dependent susceptibility to Cryptococcus neoformans in mice. Infect. Immun. 71:4815-4817. http://dx.doi.org/10.1128/IAI.71.8.4815-4817.2003.
11. McClelland EE, Perrine WT, Potts WK, Casadevall A. 2005. Relationship of virulence factor expression to evolved virulence in mouse-passaged Cryptococcus neoformans lines. Infect. Immun. 73:7047-7050. http:// dx.doi.org/10.1128/IAI.73.10.7047-7050.2005.
12. Pedroso RS, Ferreira JC, Lavrador MA, Maffei CM, Candido RC. 2009. Evaluation of the experimental inoculation of Cryptococcus albidus and Cryptococcus laurentii in normal mice: virulence factors and molecular profile before and after animal passage. Mycopathologia 168:59-72. http://dx.doi.org/10.1007/s11046-009-9202-z.
13. Fries BC, Casadevall A. 1998. Serial isolates of Cryptococcus neoformans from patients with AIDS differ in virulence for mice. J. Infect. Dis. 178: 1761-1766. http://dx.doi.org/10.1086/314521.
14. Schiappa D, Gueyikian A, Kakar S, Alspaugh JA, Perfect JR, Williamson PR. 2002. An auxotrophic pigmented Cryptococcus neoformans strain causing infection of the bone marrow. Med. Mycol. 40:1-5. http:// dx.doi.org/10.1080/714031078.
15. Pedroso RS, Lavrador MA, Ferreira JC, Candido RC, Maffei CM. 2010. Cryptococcus neoformans var. grubii-pathogenicity of environmental isolates correlated to virulence factors, susceptibility to fluconazole and molecular profile. Mem. Inst. Oswaldo Cruz 105:993-1000. http:// dx.doi.org/10.1590/S0074-02762010000800008.
16. Steenbergen JN, Nosanchuk JD, Malliaris SD, Casadevall A. 2003. Cryptococcus neoformans virulence is enhanced after growth in the genetically malleable host Dictyostelium discoideum. Infect. Immun. 71: 4862-4872. http://dx.doi.org/10.1128/IAI.71.9.4862-4872.2003.
17. Currie B, Sanati H, Ibrahim AS, Edwards JE, Jr, Casadevall A, Ghannoum MA. 1995. Sterol compositions and susceptibilities to amphotericin B of environmental Cryptococcus neoformans isolates are changed by murine passage. Antimicrob. Agents Chemother. 39:1934-1937. http:// dx.doi.org/10.1128/AAC.39.9.1934.
18. Waterman SR, Hacham M, Hu G, Zhu X, Park YD, Shin S, Panepinto J, Valyi-Nagy T, Beam C, Husain S, Singh N, Williamson PR. 2007. Role of a CUF1-CTR4 copper regulatory axis in the virulence of Cryptococcus neoformans. J. Clin. Invest. 117:794-802. http://dx.doi.org/10.1172/ JCI30006.
19. Magditch DA, Liu TB, Xue C, Idnurm A. 2012. DNA mutations mediate microevolution between host-adapted forms of the pathogenic fungus Cryptococcus neoformans. PLoS Pathog. 8:e1002936. http://dx.doi.org/ 10.1371/journal.ppat.1002936.
20. Bunting LA, Neilson JB, Bulmer GS. 1979. Cryptococcus neoformans: gastronomic delight of a soil ameba. Sabouraudia 17:225-232. http:// dx.doi.org/10.1080/00362177985380341.
21. Neilson JB, Ivey MH, Bulmer GS. 1978. Cryptococcus neoformans: pseudohyphal forms surviving culture with Acanthamoeba polyphaga. Infect. Immun. 20:262-266.
22. Ruiz A, Neilson JB, Bulmer GS. 1982. Control of Cryptococcus neoformans in nature by biotic factors. Sabouraudia 20:21-29. http://dx.doi.org/ 10.1080/00362178285380051.
23. Georgatsou E, Alexandraki D. 1999. Regulated expression of the Saccharomyces cerevisiae Fre1p/Fre2p Fe/Cu reductase related genes. Yeast 15: 573-584. http://dx.doi.org/10.1002/(SICI)1097-0061(199905)15:7_573:: AID-YEA404_3.0.CO;2-7.
24. Askwith CC, de Silva D, Kaplan J. 1996. Molecular biology of iron acquisition in Saccharomyces cerevisiae. Mol. Microbiol. 20:27-34. http:// dx.doi.org/10.1111/j.1365-2958.1996.tb02485.x.
25. Dancis A, Yuan DS, Haile D, Askwith C, Eide D, Moehle C, Kaplan J, Klausner RD. 1994. Molecular characterization of a copper transport protein in S. cerevisiae: an unexpected role for copper in iron transport. Cell 76:393-402. http://dx.doi.org/10.1016/0092-8674(94)90345-X.
26. Caza M, Kronstad JW. 2013. Shared and distinct mechanisms of iron acquisition by bacterial and fungal pathogens of humans. Front. Cell. Infect. Microbiol. 3:80. http://dx.doi.org/10.3389/fcimb.2013.00080.
27. Jennings A, Bennett JE, Young V. 1968. Identification of Cryptococcus neoformans in a routine clinical laboratory. Mycopathol. Mycol. Appl. 35:256-264. http://dx.doi.org/10.1007/BF02050740.
28. Meyer W, Aanensen DM, Boekhout T, Cogliati M, Diaz MR, Esposto MC, Fisher M, Gilgado F, Hagen F, Kaocharoen S, Litvintseva AP, Mitchell TG, Simwami SP, Trilles L, Viviani MA, Kwon-Chung J. 2009. Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii. Med. Mycol. 47:561-570. http://dx.doi.org/ 10.1080/13693780902953886.
29. Franzot SP, Mukherjee J, Cherniak R, Chen LC, Hamdan JS, Casadevall A. 1998. Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes. Infect. Immun. 66:89-97.
30. Williamson PR. 1994. Biochemical and molecular characterization of the diphenol oxidase of Cryptococcus neoformans: identification as a laccase. J. Bacteriol. 176:656-664.
31. Hu G, Hacham M, Waterman SR, Panepinto J, Shin S, Liu X, Gibbons J, Valyi-Nagy T, Obara K, Jaffe HA, Ohsumi Y, Williamson PR. 2008. PI3K signaling of autophagy is required for starvation tolerance and virulence of Cryptococcus neoformans. J. Clin. Invest. 118:1186-1197. http:// dx.doi.org/10.1172/JCI32053.
32. Price MS, Betancourt-Quiroz M, Price JL, Toffaletti DL, Vora H, Hu G, Kronstad JW, Perfect JR. 2011. Cryptococcus neoformans requires a functional glycolytic pathway for disease but not persistence in the host. mBio 2:e00103-11. http://dx.doi.org/10.1128/mBio.00103-11.
33. Finegold AA, Shatwell KP, Segal AW, Klausner RD, Dancis A. 1996. Intramembrane bis-heme motif for transmembrane electron transport conserved in a yeast iron reductase and the human NADPH oxidase. J. Biol. Chem. 271:31021-31024. http://dx.doi.org/10.1074/jbc.271.49.31021.
34. Zhang X, Krause KH, Xenarios I, Soldati T, Boeckmann B. 2013. Evolution of the ferric reductase domain (FRD) superfamily: modularity, functional diversification, and signature motifs. PLoS One 8:e58126. http://dx.doi.org/10.1371/journal.pone.0058126.
35. Nyhus KJ, Jacobson ES. 1999. Genetic and physiologic characterization of ferric-cupric reductase constitutive mutants of Cryptococcus neoformans. Infect. Immun. 67:2357-2365.
36. Georgatsou E, Mavrogiannis LA, Fragiadakis GS, Alexandraki D. 1997. The yeast Fre1p/Fre2p cupric reductases facilitate copper uptake and are regulated by the copper-modulated Mac1p activator. J. Biol. Chem. 272: 13786-13792. http://dx.doi.org/10.1074/jbc.272.21.13786.
37. Feldmesser M, Kress Y, Novikoff P, Casadevall A. 2000. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect. Immun. 68:4225-4237. http://dx.doi.org/10.1128/ IAI.68.7.4225-4237.2000.
38. Fries BC, Chen F, Currie BP, Casadevall A. 1996. Karyotype instability in Cryptococcus neoformans infection. J. Clin. Microbiol. 34:1531-1534.
39. Crichton RR, Pierre JL. 2001. Old iron, young copper: from Mars to Venus. Biometals 14:99-112. PubMed. doi:10.1023/A:1016710810701. PubMed.
40. Kosman DJ. 2003. Molecular mechanisms of iron uptake in fungi. Mol. Microbiol. 47:1185-1197. http://dx.doi.org/10.1046/j.1365-2958.2003.03368.x.
41. Silva MG, Schrank A, Bailao EF, Bailao AM, Borges CL, Staats CC, Parente JA, Pereira M, Salem-Izacc SM, Mendes-Giannini MJ, Oliveira RM, Silva LK, Nosanchuk JD, Vainstein MH, de Almeida Soares CM. 2011. The homeostasis of iron, copper, and zinc in Paracoccidioides brasiliensis, Cryptococcus neoformans var. grubii, and Cryptococcus gattii: a comparative analysis. Front. Microbiol. 2:49. http://dx.doi.org/10.3389/ fmicb.2011.00049.
42. Shi X, Stoj C, Romeo A, Kosman DJ, Zhu Z. 2003. Fre1p Cu2+ reduction and Fet3p Cu1+ oxidation modulate copper toxicity in Saccharomyces cerevisiae. J. Biol. Chem. 278:50309-50315. http://dx.doi.org/10.1074/ jbc.M307019200.
43. Hassett R, Kosman DJ. 1995. Evidence for Cu(II) reduction as a component of copper uptake by Saccharomyces cerevisiae. J. Biol. Chem. 270: 128-134. http://dx.doi.org/10.1074/jbc.270.1.128.
44. Adler A, Park YD, Larsen P, Nagarajan V, Wollenberg K, Qiu J, Myers TG, Williamson PR. 2011. A novel specificity protein 1 (SP1)-like gene regulating protein kinase C-1 (Pkc1)-dependent cell wall integrity and virulence factors in Cryptococcus neoformans. J. Biol. Chem. 286: 20977-20990. http://dx.doi.org/10.1074/jbc.M111.230268.
45. Jung WH, Saikia S, Hu G, Wang J, Fung CK, D'Souza C, White R, Kronstad JW. 2010. HapX positively and negatively regulates the transcriptional response to iron deprivation in Cryptococcus neoformans. PLoS Pathog. 6:e1001209. http://dx.doi.org/10.1371/journal.ppat.1001209.
46. Polacheck I, Hearing VJ, Kwon-Chung KJ. 1982. Biochemical studies of phenoloxidase and utilization of catecholamines in Cryptococcus neoformans. J. Bacteriol. 150:1212-1220.
47. Jung WH, Kronstad JW. 2011. The iron-responsive, GATA-type transcription factor Cir1 influences mating in Cryptococcus neoformans. Mol. Cells 31:73-77. http://dx.doi.org/10.1007/s10059-011-0011-0.
48. Liu L, Tewari RP, Williamson PR. 1999. Laccase protects Cryptococcus neoformans from antifungal activity of alveolar macrophages. Infect. Immun. 67:6034-6039.
49. Ma H, Hagen F, Stekel DJ, Johnston SA, Sionov E, Falk R, Polacheck I, Boekhout T, May RC. 2009. The fatal fungal outbreak on Vancouver Island is characterized by enhanced intracellular parasitism driven by mitochondrial regulation. Proc. Natl. Acad. Sci. U. S. A. 106:12980-12985. http://dx.doi.org/10.1073/pnas.0902963106.
50. Gutierrez MC, Brisse S, Brosch R, Fabre M, Omaïs B, Marmiesse M, Supply P, Vincent V. 2005. Ancient origin and gene mosaicism of the progenitor of Mycobacterium tuberculosis. PLoS Pathog. 1:e5. http:// dx.doi.org/10.1371/journal.ppat.0010005.
51. Fan W, Kraus PR, Boily MJ, Heitman J. 2005. Cryptococcus neoformans gene expression during murine macrophage infection. Eukaryot. Cell 4:1420-1433. http://dx.doi.org/10.1128/EC.4.8.1420-1433.2005.
52. Chen Y, Toffaletti DL, Tenor JL, Litvintseva AP, Fang C, Mitchell TG, McDonald TR, Nielsen K, Boulware DR, Bicanic T, Perfect JR. 2014. The Cryptococcus neoformans transcriptome at the site of human meningitis. mBio 5:e01087-13. http://dx.doi.org/10.1128/mBio.01087-13.
53. Wilson DE, Bennett JE, Bailey JW. 1968. Serologic grouping of Cryptococcus neoformans. Proc. Soc. Exp. Biol. Med. 127:820-823. http:// dx.doi.org/10.3181/00379727-127-32812.
54. Varma A, Edman JC, Kwon-Chung KJ. 1992. Molecular and genetic analysis of URA5 transformants of Cryptococcus neoformans. Infect. Immun. 60:1101-1108.
55. Nyhus KJ, Wilborn AT, Jacobson ES. 1997. Ferric iron reduction by Cryptococcus neoformans. Infect. Immun. 65:434-438.
56. Erickson T, Liu L, Gueyikian A, Zhu X, Gibbons J, Williamson PR. 2001. Multiple virulence factors of Cryptococcus neoformans are dependent on VPH1. Mol. Microbiol. 42:1121-1131. http://dx.doi.org/10.1046/ j.1365-2958.2001.02712.x.
57. Edgar RC. 2004. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32:1792-1797. http:// dx.doi.org/10.1093/nar/gkh340.
58. Swofford D. 2003. PAUP, phylogenetic analysis using parsimony. Sinauer Associates, Sunderland, MA.
59. Jones DT, Taylor WR, Thornton JM. 1994. A model recognition approach to the prediction of all-helical membrane protein structure and topology. Biochemistry 33:3038-3049. http://dx.doi.org/10.1021/ bi00176a037.
60. Käll L, Krogh A, Sonnhammer EL. 2004. A combined transmembrane topology and signal peptide prediction method. J. Mol. Biol. 338: 1027-1036. http://dx.doi.org/10.1016/j.jmb.2004.03.016.
61. Cox CD. 1994. Deferration of laboratory media and assays for ferric and ferrous ions. Methods Enzymol. 235:315-329. http://dx.doi.org/10.1016/ 0076-6879(94)35150-3.
62. Shapiro S, Beenhouwer DO, Feldmesser M, Taborda C, Carroll MC, Casadevall A, Scharff MD. 2002. Immunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3. Infect. Immun. 70:2598-2604. http://dx.doi.org/10.1128/ IAI.70.5.2598-2604.2002.
63. Goujon M, McWilliam H, Li W, Valentin F, Squizzato S, Paern J, Lopez R. 2010. A new bioinformatics analysis tools framework at EMBL-EBI. Nucleic Acids Res. 38:W695-W699. http://dx.doi.org/10.1093/nar/ gkq313.
64. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, Thompson JD, Gibson TJ, Higgins DG. 2007. ClustalW2 and ClustalX version 2. Bioinformatics 23:2947-2948. http://dx.doi.org/10.1093/bioinformatics/ btm404.
65. Panepinto J, Komperda K, Frases S, Park YD, Djordjevic JT, Casadevall A, Williamson PR. 2009. Sec6-dependent sorting of fungal extracellular exosomes and laccase of Cryptococcus neoformans. Mol. Microbiol. 71(5): 1165-1176.
66. Wormley FL, Jr, Perfect JR. 2005. Immunology of infection caused by Cryptococcus neoformans. Methods Mol. Med. 118:193-198.
67. Lin X, Hull CM, Heitman J. 2005. Sexual reproduction between partners of the same mating type in Cryptococcus neoformans. Nature 434: 1017-1021.